Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher B Cole

Showing results (11-20 of 20) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 20 results.
Cancers|February 25, 2023
SMAC Mimetics Synergistically Cooperate with HDAC Inhibitors Enhancing TNF-α Autocrine SignalingYusuke Shibuya, Kei Kudo, Kristen P Zeligs, et al.
Frontiers in Immunology|March 12, 2026
IL 15 enhances preclinical efficacy of anti-core 1 O-glycans monoclonal antibody NEO-201 against human endometrial and ovarian cancerJamie Hur, Massimo Fantini, Lidia Hernandez, et al.
Addiction (Abingdon, England)|September 19, 2017
Genome-wide association study of a nicotine metabolism biomarker in African American smokers: impact of chromosome 19 genetic influencesMeghan J Chenoweth, Jennifer J Ware, Andy Z X Zhu, et al.
The Journal of Clinical Investigation|September 6, 2017
Haploinsufficiency for DNA methyltransferase 3A predisposes hematopoietic cells to myeloid malignanciesChristopher B Cole, David A Russler-Germain, Shamika Ketkar, et al.
Journal of Experimental & Clinical Cancer Research : CR|March 29, 2023
First-in-human phase 1 clinical trial of anti-core 1 O-glycans targeting monoclonal antibody NEO-201 in treatment-refractory solid tumorsChristopher B Cole, Maria Pia Morelli, Massimo Fantini, et al.
Journal of Experimental & Clinical Cancer Research : CR|April 26, 2023
Correction: First-in-human phase 1 clinical trial of anti-core 1 O-glycans targeting monoclonal antibody NEO-201 in treatment-refractory solid tumorsChristopher B Cole, Maria Pia Morelli, Massimo Fantini, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 13, 2022
Intraperitoneal Monocytes plus IFNs as a Novel Cellular Immunotherapy for Ovarian Cancer: Mechanistic Characterization and Results from a Phase I Clinical TrialDaniel S Green, Franklin Ning, Anna Duemler, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 17, 2023
Correction: Intraperitoneal Monocytes plus IFNs as a Novel Cellular Immunotherapy for Ovarian Cancer: Mechanistic Characterization and Results from a Phase I Clinical TrialDaniel S Green, Franklin Ning, Anna Duemler, et al.
Elife|June 24, 2020
A community-maintained standard library of population genetic modelsJeffrey R Adrion, Christopher B Cole, Noah Dukler, et al.
Psychiatric Genetics|September 9, 2016
Rapporteur summaries of plenary, symposia, and oral sessions from the XXIIIrd World Congress of Psychiatric Genetics Meeting in Toronto, Canada, 16-20 October 2015Gwyneth Zai, Bonnie Alberry, Janine Arloth, et al.
Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Cancers|February 25, 2023
SMAC Mimetics Synergistically Cooperate with HDAC Inhibitors Enhancing TNF-α Autocrine SignalingYusuke Shibuya, Kei Kudo, Kristen P Zeligs, et al.
Frontiers in Immunology|March 12, 2026
IL 15 enhances preclinical efficacy of anti-core 1 O-glycans monoclonal antibody NEO-201 against human endometrial and ovarian cancerJamie Hur, Massimo Fantini, Lidia Hernandez, et al.
Addiction (Abingdon, England)|September 19, 2017
Genome-wide association study of a nicotine metabolism biomarker in African American smokers: impact of chromosome 19 genetic influencesMeghan J Chenoweth, Jennifer J Ware, Andy Z X Zhu, et al.
The Journal of Clinical Investigation|September 6, 2017
Haploinsufficiency for DNA methyltransferase 3A predisposes hematopoietic cells to myeloid malignanciesChristopher B Cole, David A Russler-Germain, Shamika Ketkar, et al.
Journal of Experimental & Clinical Cancer Research : CR|March 29, 2023
First-in-human phase 1 clinical trial of anti-core 1 O-glycans targeting monoclonal antibody NEO-201 in treatment-refractory solid tumorsChristopher B Cole, Maria Pia Morelli, Massimo Fantini, et al.
Journal of Experimental & Clinical Cancer Research : CR|April 26, 2023
Correction: First-in-human phase 1 clinical trial of anti-core 1 O-glycans targeting monoclonal antibody NEO-201 in treatment-refractory solid tumorsChristopher B Cole, Maria Pia Morelli, Massimo Fantini, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 13, 2022
Intraperitoneal Monocytes plus IFNs as a Novel Cellular Immunotherapy for Ovarian Cancer: Mechanistic Characterization and Results from a Phase I Clinical TrialDaniel S Green, Franklin Ning, Anna Duemler, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 17, 2023
Correction: Intraperitoneal Monocytes plus IFNs as a Novel Cellular Immunotherapy for Ovarian Cancer: Mechanistic Characterization and Results from a Phase I Clinical TrialDaniel S Green, Franklin Ning, Anna Duemler, et al.
Elife|June 24, 2020
A community-maintained standard library of population genetic modelsJeffrey R Adrion, Christopher B Cole, Noah Dukler, et al.
Psychiatric Genetics|September 9, 2016
Rapporteur summaries of plenary, symposia, and oral sessions from the XXIIIrd World Congress of Psychiatric Genetics Meeting in Toronto, Canada, 16-20 October 2015Gwyneth Zai, Bonnie Alberry, Janine Arloth, et al.
Pageof 2